Clinical trial / 2021
Resveratrol supplementation improved menstrual cyclicity and reduced hair loss in women with PCOS without altering androgen, insulin, or lipid levels.
In a randomized trial, 78 women aged 18-40 years with PCOS received either 1000 mg resveratrol or 1000 mg placebo daily for 3 months. Compared to placebo, the resveratrol group had a significantly higher regular menstruation rate (76.47% vs. 51.61%; p = 0.03) and lower hair loss (32.10% vs. 68.00%; p = 0.009). No significant differences were found between groups for ovarian and adrenal androgens, SHBG, FAI, glycoinsulinemic metabolism, or lipid profile, and weight did not change relative to placebo.
- Study type
- Randomized controlled trial
- Who was studied
- 78 women aged 18-40 years diagnosed with PCOS
- What was measured
- Menstrual cyclicity, acne, hair loss, androgens, glycoinsulinemic metabolism, lipid profile
THE PAPER
Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS.
Mansour A, Samadi M, Sanginabadi M, Gerami H, Karimi S, Hosseini S, Shirzad N, Hekmatdoost A, Mahdavi-Gorabi A, Mohajeri-Tehrani MR, Qorbani M. Clin Nutr, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.